Background. Although guidelines indicate when patients are eligible for antihypertensives and statins, little is known about whether general practitioners (GPs) follow this guidance.Objec-tive. To determine the factors influencing GPs decisions to pre-scribe cardiovascular prevention drugs. Design of Study. Secondary analysis of data collected on patients whose cardio-vascular risk factors weremeasured as part of a controlled study comparing nurse-led risk assessment (four practices) with GP-led risk assessment (two practices).Setting. Six general practices in theWestMidlands, England.Patients. Five hundred patients: 297 assessed by the project nurse, 203 assessed by their GP. Measurements. Cardiovascular risk factor data and whether statin...
Background: Cardiovascular disease is a leading cause of death. It is important to identify patient ...
Background: Cardiovascular disease is a leading cause of death. It is important to identify patient ...
BACKGROUND: Guidelines indicate eligibility for lipid lowering drugs, but it is not known to what ex...
Background. Although guidelines indicate when patients are eligible for antihypertensives and statin...
Guidelines indicate eligibility for lipid lowering drugs, but it is not known to what extent GPs' fo...
Background: Cardiovascular disease is a leading cause of death. It is important to identify patient ...
Guidelines indicate eligibility for lipid lowering drugs, but it is not known to what extent GPs' fo...
Guidelines indicate eligibility for lipid lowering drugs, but it is not known to what extent GPs' fo...
BACKGROUND: Guidelines indicate eligibility for lipid lowering drugs, but it is not known to what ex...
Various guidelines have been developed to sup-port general practitioners (GPs) in their cardio-vascu...
Objective: To understand general practitioners' (GPs) use of individual risk factors (blood pressure...
Objective: To understand general practitioners' (GPs) use of individual risk factors (blood pressure...
Cardiovascular absolute risk (CVAR) assessment involves a multifactorial approach to determine a per...
Objective. Guidelines on primary prevention of cardiovascular disease (CVD) emphasize identifying hi...
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, p...
Background: Cardiovascular disease is a leading cause of death. It is important to identify patient ...
Background: Cardiovascular disease is a leading cause of death. It is important to identify patient ...
BACKGROUND: Guidelines indicate eligibility for lipid lowering drugs, but it is not known to what ex...
Background. Although guidelines indicate when patients are eligible for antihypertensives and statin...
Guidelines indicate eligibility for lipid lowering drugs, but it is not known to what extent GPs' fo...
Background: Cardiovascular disease is a leading cause of death. It is important to identify patient ...
Guidelines indicate eligibility for lipid lowering drugs, but it is not known to what extent GPs' fo...
Guidelines indicate eligibility for lipid lowering drugs, but it is not known to what extent GPs' fo...
BACKGROUND: Guidelines indicate eligibility for lipid lowering drugs, but it is not known to what ex...
Various guidelines have been developed to sup-port general practitioners (GPs) in their cardio-vascu...
Objective: To understand general practitioners' (GPs) use of individual risk factors (blood pressure...
Objective: To understand general practitioners' (GPs) use of individual risk factors (blood pressure...
Cardiovascular absolute risk (CVAR) assessment involves a multifactorial approach to determine a per...
Objective. Guidelines on primary prevention of cardiovascular disease (CVD) emphasize identifying hi...
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, p...
Background: Cardiovascular disease is a leading cause of death. It is important to identify patient ...
Background: Cardiovascular disease is a leading cause of death. It is important to identify patient ...
BACKGROUND: Guidelines indicate eligibility for lipid lowering drugs, but it is not known to what ex...